Publication | Open Access

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer

OncologyMedicinePhase Ii StudyBronchial NeoplasmPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyLung CancerOral Talactoferrin